This report contains market size and forecasts of Erectile Dysfunction Medicine in global, including the following market information:
Global Erectile Dysfunction Medicine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Erectile Dysfunction Medicine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Erectile Dysfunction Medicine companies in 2021 (%)
The global Erectile Dysfunction Medicine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Viagra Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Erectile Dysfunction Medicine include Pfizer, Inc., Dong-A ST Co., Ltd., Eli Lilly and Company, Bayer AG, Vivus, Inc., Teva Pharmaceutical Industries Ltd., SK Chemicals, Meda Pharmaceuticals, Inc. and Cristalia Produtos Quimicos Farmaceuticos Ltda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Erectile Dysfunction Medicine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Erectile Dysfunction Medicine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Erectile Dysfunction Medicine Market Segment Percentages, by Type, 2021 (%)
Viagra
Cialis
Levitra
Stendra
Global Erectile Dysfunction Medicine Market, by Distribution Channel, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Erectile Dysfunction Medicine Market Segment Percentages, by Distribution Channel, 2021 (%)
Online Pharmacies
Retail Pharmacies
Hospital
Global Erectile Dysfunction Medicine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Erectile Dysfunction Medicine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Erectile Dysfunction Medicine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Erectile Dysfunction Medicine revenues share in global market, 2021 (%)
Key companies Erectile Dysfunction Medicine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Erectile Dysfunction Medicine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer, Inc.
Dong-A ST Co., Ltd.
Eli Lilly and Company
Bayer AG
Vivus, Inc.
Teva Pharmaceutical Industries Ltd.
SK Chemicals
Meda Pharmaceuticals, Inc.
Cristalia Produtos Quimicos Farmaceuticos Ltda
Apricus Biosciences, Inc.
Futura Medical plc.